Comments for CAH - Stockpickr! Your Source for Stock Ideas

Comments for CAH

Added By	Comments	Type	Date Added
barrons2	You can see MedcoHealth (MHS), Cardinal Health (CAH) and Quest Diagnostics (DGX) rallying, another cohort that's struggling to put in a recession bottom.	Love	July 02, 2008
lisariddle	Believe in company growth	Love	June 13, 2008
paul simenauer	TP $74.00	Love	May 12, 2008
High Dividends	17%	Love	May 10, 2008
DKEMP	Broker recommendation	Love	November 24, 2007
barrons2	In light of expected mid-teens earnings growth in coming years, Cardinal shares seem cheap, particularly compared with rivals'. Upside potential could be 20% to 45% higher.	Love	October 06, 2007
tilak	Cardinal Health, Inc.	Love	October 05, 2007
JCBB	profitable	Love	September 23, 2007
johnem	i'm gittin older	Love	August 26, 2007
sarah z	Cardinal Health is in this week’s portfolio. The company’s board recently approved a $2 billion buyback plan and increased its quarterly dividend to 12 cents. The two-year repurchase plan immediately follows a $4.1 billion buyback plan put forward back in July 2006. The buyback and dividend are a step toward the company's long term goal to return 50% of its operating cash flow to shareholders. In the past two years, Cardinal said it has returned about $5.5 billion to its investors. Last Thursday, Dublin, Ohio's medical products provider also reported encouraging fourth-quarter earnings. The sale of its pharmaceutical technologies and services segment for $3.3 billion forced profit to climb $902.2 million or $2.33 per share, almost three times better than last years profit of $321.1 million or 76 cents a share. Even without the sale of its pharmaceutical technologies business, the company still would have earned 89 cents a share. Profits from continuing operations dropped slightly, mainly due to the $1.42 billion purchase of Viasys Corp., which directors believe will a long-term catalyst. Revenue surged 5% to $22.26 billion. R. Kerry Clark, Chief Executive Officer of Cardinal Health said: "Fiscal 2007 was a strong year and marks an inflection point in the performance of the company. In the fourth quarter, our core supply chain services sector performed as we previously indicated, and delivered robust full-year results. Within the sector, pharmaceutical supply chain had a good year and we continue to anticipate a strong fiscal 2008 for this business.” Robert W. Baird and Co. are still bullish on CAH. The research firm gave the company an Outperform rating based on excellent performance during 2007 and strong outlook for the future. Baird liked to see positive 4th quarter earnings driven by factors that played out as they expected. Strong performance of its higher-growth and higher-profit businesses along with non-operational benefits, like buybacks and higher dividends, will drive long-term results. At current levels, Cardinal appears attractive, and Baird gave the stock an $88 price target, nearly a 30% premium from its last closing price of $68.	Love	August 15, 2007
prodifotl	inherited	Love	August 14, 2007
paul simenauer	Rising ROE	Love	June 11, 2007
paul simenauer	Rising ROE	Love	June 11, 2007
gurn	Pharmacuetical distribution.	Love	May 26, 2007
sarah z	- $81,895 million in revenues - The country's second largest drug distributor	Love	April 17, 2007
Admin	6. Cardinal Health Inc (CAH) and McKesson Corporation (MCK).	Love	February 22, 2007
Greg NTG1 Parker	Two bear indicators here: 1) look at the 5 year chart -- from 70 down to 40 and back to 70. This is the "treadmill to nowhere". 2) look at the tiny, microscopic dividend. Health care is 14% of the total U.S. economy. Surely a company that is kicking ass and taking names in a prime sector can do better than this.	Hate	February 04, 2007
Ted Kirpach	health care	Love	January 29, 2007
Martin Weber	growth	Hate	December 17, 2006